| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-19 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.33 | 3e-19 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.43 | 8e-18 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-15 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-15 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-14 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-14 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-12 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-11 |